Overview of PJT Partners?

Did some searches but all the threads are from when PJT was first announced with BX spinning off its M&A practice. Does anyone have any idea about PJT as a firm? Deal flow? "Preftige"? Analyst class composition/training? Exit opps?

Looking at their SA process and curious how their interview process will be and what to expect in general from the new firm. Obviously, there's a lot more out there about applying to/working at the more established BBs, EBs, MMs, etc.

Review of PJT Partners Blackstone History

In October of 2015 Blackstone announced the successful completion of a spin-off of their advisory services. At this point they had successfully combined Park Hill Group with PJT Capital to form PJT Partners. The newly formed investment bank includes mergers and Acquisitions, restructuring and reorganization services. Additionally, the chief executive of Blackstone, Stephen Schwarzman noted that the independence of PJT would allow the firm to operate in the advisory space without a fear of conflict of interest. Paul Tubman, Chairman, and CEO of PJT Partners made the following remarks in an

Today marks the culmination of this past year’s hard work and thoughtful planning, and I am extremely excited about the future of PJT Partners as a stand-alone public company. Combining the 30-year legacy of an established firm with the entrepreneurial culture of a start-up, PJT Partners brings together three best-in-class businesses – Advisory, Restructuring and Park Hill. As a next-generation, advisory-focused investment bank that is free of constraints, we are committed to providing our clients with unparalleled, strategic advice while creating long-term value for our shareholders.

A majority of Blackstone's advisory operations was transferred to PJT Partners during the merger. In the year before the merger, advisory services made 4.5 million in profits according to this

People make firms, not name. Names are made because of the great people who work at these firms. Please keep that in mind when thinking about any firm you choose to work at or talk about.

And PE/HF funds are the most sophisticated people in finance. If I re-branded Goldman Sachs --> Morgan Sachs tomorrow...nothing would change in terms of exit ops. The only thing that would change is that your parents won't know where you work.

Recent PJT Deals

Most recently PJT Partners has advised Impact Bio Medicines in an acquisition by Celgene for 7 billion dollars. Celgene is a biotechnology company that develops and commercializes medicines for cancer and inflammatory disorders. Celgene has been pressured into making acquisitions to diversify by investors. This came after the under-performance of a new psoriasis treatment drug and a subsequent scale back of their financial outlook.

    Other Notable Deals
  • £25 billion: Sky and 21st Century Fox
  • $4.8 billion: Yahoo and Verizon
  • $21 billion: Rock-Tenn and MeadWestvaco
  • $13 billion: Catamaran and United Healthcare
  • $4.4 billion: Lionsgate and Starz
  • $3.8 billion: Comcast and Dreamworks

As listed on pjtpartners.com

PJT Partners Salary and Bonus

Average base and average bonus as reported in Wall Street Oasis 2018 Investment Banking Industry Report

    Summer Analyst
  • Average Base: 71.5k
    First Year Analyst
  • Average Base: 80.9k
  • Average Bonus: 88.1k

PJT Partners Exit Opportunities for Analysts and Associates

NY: Destinations of PJT Partners analysts and associates

  • Berkshire Partners
  • Harvest Partners
  • Spectrum Equity
  • Madison Dearborn Partners
  • Centerbridge Partners
  • King Street
  • Hound Partners
  • Warburg Pincus
  • Darsana
  • Apollo Capital Management
  • Silver Point
  • Governor's Lane
  • Oaktree Capital Management
  • Maverick
  • Baupost Group
  • General Atlantic
  • PJT Partners: Professional Growth and Career Opportunities

    PJT Partners has one of the hardest interviews but offers one of the most rewarding work environments. Company Statistics as reported in Wall Street Oasis 2018 Investment Banking Industry Report.
    Percentile Scores: Company Review

    • 80th percentile for professional growth.
    • 80th percentile for career advancement opportunities
    • 90th percentile for recognition and praise of good work
    • 90th percentile for compensation
    • 90th percentile for leadership abilities of senior management
    • 80th percentile for reputation

    If you would like to know more information about the top firms on Wall Street then take a look at the IB Industry report. This report is constantly updated and contains compensation by position, company statistics, lifestyle rankings, and more! Visit the report on WSO.

    Read More About PJT on WSO

    Preparing for Investment Banking Interviews?

    The WSO investment banking interview course is designed by countless professionals with real world experience, tailored to people aspiring to break into the industry. This guide will help you learn how to answer these questions and many, many more.

    Investment Banking Interview Course Here

     

    It's just Blackstone's advisory business (so M&A and Restructuring) under a new name. The firm structure is similar to Evercore's. Historically, kids have gone there (BX Restructuring and M&A) because exit opps have always been better than other BBs/EBs/top groups - probably same thing will continue.

     

    Which position did you guys apply for? I'm curious about the Real Estate position vs. the Restructuring, etc. Only recruiting for Real Estate on campus here, so wondering about rep, etc.

     

    Don't know anything about the analyst experience, but a good number of the 2015 summer analysts seemed to want to go somewhere else. I interviewed 4-5 of them (all with return offers) for my EB regional office alone

     
    trueblue:

    Don't know anything about the analyst experience, but a good number of the 2015 summer analysts seemed to want to go somewhere else. I interviewed 4-5 of them (all with return offers) for my EB regional office alone

    It will be tough for the first few incoming classes.

    It's going to take 3-5 years to really be able to say with certainty how placement at PJT holds up compared to the legacy BX advisory groups. The 2014 analyst class recruited as Blackstone analysts. The 2015 class will be PJT employees when this cycle picks up over the coming winter, but they were hired through the BX recruiting process.

    Not surprised that the 2016 class wanted out. The BX analyst alumni network effect is yet to be proven for the PJT analyst classes. It's fine for the current guys (all the 2015 analysts interned when the 2012 analysts were in the last few weeks and the 2013 analysts were just becoming second-years) but remains to be seen for later classes.

    I think the big thing will be whether or not they maintain the same sky-high standards in recruiting. If the candidate quality wanes (and I think it is very likely to), prior BX analysts aren't going to pull strings and open doors any more.

    I am permanently behind on PMs, it's not personal.
     

    This is interesting because several of the BX summers analysts and analysts are looking elsewhere instead of going to PJT. The uncertainty is probably driving a lot junior professionals away. As with any new shop, it's going to take a while to build a brand image.

    Regarding PJT's new recruiting habits, it seems like its changing. BX, I assume, only conducted OCR at Wharton and Harvard with general postings at schools like NYU / Michigan / Georgetown / Duke etc.

    I know PJT is now conducting OCR at NYU and probably at some of the above schools as well. They will probably also try to take a larger class and try to become like and compete with Evercore, Moelis etc.

     

    Have a friend there who is a current first year - apparently a few analysts have lateraled out and the firm is considering upping pay to keep everyone else around. Reasons for analysts lateraling have been the differences between the typical BX M&A workload, aka very little, and the more aggressive workload that analysts are experiencing now.

     

    M&A superdays are next Tuesday, Thursday. Restructuring superdays are Wednesday, Thursday. I know they are not coming back to campus for OCR so it appears that all hiring will be over these two days.

     

    Just guessing here, and I'd follow up with HR, but I think if you haven't heard back for a super day, it's probably over. If you had your super day and haven't heard yet, you're probably still in the running as of now

     

    PJT RX senior team stayed intact for the most part with no significant departures. However, I can absolutely see PJT having a tough time competing for deals at least in the first couple of years against Lazard and others due to the unproven brand image.

    An example of this was UBS RX team who used to be a very good RX team (maybe not Laz/HL/BX level) but still very respectable and when the head guy started his own shop called GLC and took his entire UBS team with him plus others, they had a lot of trouble winning deals because of the lack of brand equity of GLC.

    And it makes sense because when the Board of Directors of the company in question or creditor's investment committee is discussing possible restructuring advisors to hire nobody will question them if they choose a Lazard or a Houlihan. But as soon as say a newly formed entity like PJT, people on the board of directors are going to say "you know what, let's go with Lazard" to play it safe. This is especially true on the debtor side since the company probably has never worked with a restructuring advisor before vs the creditor side where winning deals are a little bit more based on relationships and track record.

     

    While the above post is valid, also realize that PJT no longer has to compete with GSO on deals.

    In the past, there were significant clashes between RX and GSO--debtors would refuse to hire the RX team on the basis that there would be (potential) conflicts of interests, so there were conflicts around if GSO would take a distressed position or RX would be the restructuring advisor of a company. Despite all the talks about the M&A conflicts of interest, the RX team probably ran into those problems much more. M&A traditionally focused on middle market deals that the BX PE platform wouldn't be a player in, but GSO and RX really played in the same space.

    I would expect the RX group to perform as well if not better.

     

    Good point and that conflict of interest with GSO was one of the major reasons why BX R&R was spun out to PJT.

    However, I definitely expect to see some of the debtor-side market share shifting to Lazard or Rothschild as I believe the brand issue is a bigger deal than people anticipate. They are obviously still in great hands with the senior team they have there and will still be a great RX group but I believe the next several years will be a rockier road for them than most people expect given their previous success.

    We'll just have to wait and see how it plays out the next couple of years for them. From an analyst perspective, I think it's still one of the better RX groups to be placed into along with Lazard and Houlihan Lokey, but don't think it is the gold-plated undisputed best that it used to be.

     

    Re: analyst experience and recruiting I'm hearing more that PJT RSSG (or PJT RX) is having a harder time competing with the top buyside opportunities out of UG (silverpoint, KKR, BX PE etc) than BX RX did, but that most still see it as the top sellside opportunity out of UG for HF exits. But at that point we're really just splitting hairs. The bottom line is we'll see how buyside recruiting goes for the next few PJT RSSG classes but personally i think it'll be a lot stronger than most are expecting.

     

    The simple fact that people are asking how PJT is should tell you enough about the transition from the legacy BX advisory groups.

    Anyone who got an offer at BX R&R took it without blinking. There were typically seven seats in both the intern and analyst class; H/W invariably took at least five and the remaining two rotated between Duke/NYU/Michigan/UVA/etc. The rare ones to decline a summer offer were the monsters who went to Silver Lake, Silver Point, or one of the BX principal divisions.

    BX M&A was mentioned in the same breath; slightly larger class (eight or nine), middle market deals instead of the lights-out unrivaled restructuring advisory mandates, easier hours, and marginally less stellar exits. It was also very rare to see someone not accept a summer or a return offer.

    While it remains to be proven how the first analyst classes will place, early signs (adding target schools past H/W; dialing up the analyst hours given the busier dealflow; unproven brand name of the firm that may make top candidates choose the safer, more proven brand) seem to indicate that it's no longer the gold standard analyst program (as measured by 'preftige,' exits, pay, and work-life balance).

    I am permanently behind on PMs, it's not personal.
     
    Best Response

    People make firms, not name. Names are made because of the great people who work at these firms. Please keep that in mind when thinking about any firm you choose to work at or talk about.

    And PE/HF funds are the most sophisticated people in finance. If I rebranded Goldman Sachs --> Morgan Sachs tomorrow...nothing would change in terms of exit ops. The only thing that would change is that your parents won't know where you work.

     

    Has anyone yet heard back for intern positions in London? I have applied for an off cycle but no news from my side though... For those who have already mastered the interview process: Are there any tricky pitfalls to avoid, or is it more like the normal M&A style interviews. I am quite confident with respect to technicals and M&A questions but consider detailed questions on RX to be my weak points.

     

    Inventore atque optio asperiores odit numquam. Ipsum consequatur eos repudiandae et doloremque vero ut omnis. Quia doloremque possimus maxime eligendi aliquid et quis repudiandae. Sed praesentium ab quia illo. Voluptas quo non inventore aut.

    Omnis in alias dicta corporis. Molestiae numquam autem nisi incidunt accusamus aut. Non quaerat officia molestiae labore. Sed quidem officiis est fugit aut eius. Et labore ducimus totam veritatis ullam aut aut. Similique quia velit et velit nesciunt qui hic et.

    Non delectus sequi et dolor nobis voluptatum qui ex. Aut perferendis quo non. Corrupti debitis aspernatur in officiis recusandae voluptatem modi et. Optio laborum quia maxime in. Quis nisi ea assumenda mollitia qui quia fugiat.

    Reiciendis nostrum totam tempora minus a. Suscipit vel enim omnis. Amet placeat consequatur beatae veniam.

     

    Delectus aut et aliquam qui illum. Omnis velit corrupti est sint nostrum voluptatem quasi. Quia provident quisquam sequi quis ab voluptatum quas. Consequuntur explicabo enim iusto magni dolorem est quam. Veniam veritatis repellendus incidunt sapiente et et.

    Voluptatem ut sed perferendis possimus quo laboriosam totam iure. Ut reiciendis non et et sapiente aut. Aut cum cupiditate et qui qui praesentium explicabo et.

    Saepe nam aut aspernatur vel assumenda eum eum beatae. Omnis autem nam nobis molestiae. Distinctio ex consectetur ea eius quasi. Rem omnis et magni quasi. Quasi culpa quisquam consequatur fugiat iste fuga.

    Nihil corrupti ipsum voluptas corporis aperiam alias odit. Ab aspernatur consequatur quis alias aliquam. Nemo eos velit quo sit in.

     

    Id dignissimos dolore dolore error quo quisquam omnis. Et ut sit numquam libero. Laboriosam at exercitationem tenetur aut dicta praesentium.

    Ipsam vel numquam adipisci est commodi esse qui. Id qui sapiente blanditiis vitae itaque excepturi ducimus. Ex ipsa debitis error a ad.

     

    Sed sed ab beatae. Consequuntur natus ducimus in ipsa facere. Laboriosam distinctio cumque dolorem. Pariatur magnam magnam est labore odit dolores soluta. Est nesciunt enim ullam. Aliquid consectetur nisi labore veniam similique accusamus et.

    Placeat nihil quibusdam rem voluptate. Qui repellat officia dolores aspernatur voluptatum debitis magnam repudiandae. Nemo debitis molestiae et ipsum quis expedita. Fugit aut et aliquam quibusdam libero eveniet. Hic veniam assumenda laudantium tenetur. Et veritatis quisquam sunt repudiandae voluptatem.

    Voluptatem nemo vel non illum pariatur nihil. Labore eos vel est adipisci accusamus necessitatibus. Rerum tempore totam ipsa saepe neque libero necessitatibus.

    Cum earum hic hic possimus neque dolorem. Dolores minima debitis ea et. Ipsam vel quae at est laudantium aut hic. Et dolor quaerat commodi repudiandae ratione excepturi.

     

    Aliquam tempora maiores numquam quia amet natus. Laboriosam consequuntur necessitatibus deserunt deserunt eos et.

    Temporibus beatae qui provident aut ut excepturi perferendis. Explicabo et iure molestiae veniam odio. Voluptas nihil autem quo autem labore laudantium. Ea sed provident voluptate ullam consectetur vel voluptas.

    Mollitia reprehenderit molestiae laudantium expedita sunt ut enim. Ut illum cupiditate qui est quidem fuga sapiente. Et quasi assumenda doloribus sit quo ipsam. Eos ut dicta voluptas est quia a. Voluptatibus mollitia est modi quia dolores deserunt cupiditate.

    Career Advancement Opportunities

    April 2024 Investment Banking

    • Jefferies & Company 02 99.4%
    • Goldman Sachs 19 98.8%
    • Harris Williams & Co. New 98.3%
    • Lazard Freres 02 97.7%
    • JPMorgan Chase 03 97.1%

    Overall Employee Satisfaction

    April 2024 Investment Banking

    • Harris Williams & Co. 18 99.4%
    • JPMorgan Chase 10 98.8%
    • Lazard Freres 05 98.3%
    • Morgan Stanley 07 97.7%
    • William Blair 03 97.1%

    Professional Growth Opportunities

    April 2024 Investment Banking

    • Lazard Freres 01 99.4%
    • Jefferies & Company 02 98.8%
    • Goldman Sachs 17 98.3%
    • Moelis & Company 07 97.7%
    • JPMorgan Chase 05 97.1%

    Total Avg Compensation

    April 2024 Investment Banking

    • Director/MD (5) $648
    • Vice President (19) $385
    • Associates (87) $260
    • 3rd+ Year Analyst (14) $181
    • Intern/Summer Associate (33) $170
    • 2nd Year Analyst (66) $168
    • 1st Year Analyst (205) $159
    • Intern/Summer Analyst (146) $101
    notes
    16 IB Interviews Notes

    “... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

    Leaderboard

    1
    redever's picture
    redever
    99.2
    2
    Secyh62's picture
    Secyh62
    99.0
    3
    BankonBanking's picture
    BankonBanking
    99.0
    4
    Betsy Massar's picture
    Betsy Massar
    99.0
    5
    kanon's picture
    kanon
    98.9
    6
    CompBanker's picture
    CompBanker
    98.9
    7
    dosk17's picture
    dosk17
    98.9
    8
    GameTheory's picture
    GameTheory
    98.9
    9
    Jamoldo's picture
    Jamoldo
    98.8
    10
    Linda Abraham's picture
    Linda Abraham
    98.8
    success
    From 10 rejections to 1 dream investment banking internship

    “... I believe it was the single biggest reason why I ended up with an offer...”